MELPHALAN for Diffuse large b-cell lymphoma stage iii: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 14 adverse event reports in the FDA FAERS database where MELPHALAN was used for Diffuse large b-cell lymphoma stage iii.

Most Reported Side Effects for MELPHALAN

Side Effect	Reports	%	Deaths	Hosp.
Off label use	2,002	12.5%	437	495
Febrile neutropenia	931	5.8%	145	419
Drug ineffective	853	5.3%	199	213
Neutropenia	810	5.0%	145	246
Mucosal inflammation	804	5.0%	131	254
Plasma cell myeloma	781	4.9%	223	99
Product use in unapproved indication	765	4.8%	144	182
Thrombocytopenia	701	4.4%	118	253
Diarrhoea	698	4.4%	95	343
Pyrexia	667	4.2%	144	346
Pneumonia	650	4.1%	254	382
Disease progression	595	3.7%	155	90
Myelodysplastic syndrome	573	3.6%	231	132
Sepsis	544	3.4%	316	247
Venoocclusive liver disease	464	2.9%	152	130